Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 10/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4226079 | 0.94 | BCHE (0.43) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL7805020 | 0.89 | PTGER4 (0.53) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL30578869 | 0.89 | BCHE (0.43) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL4963194 | 0.89 | BCHE (0.43) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL5808907 | 0.86 | ALDH1A1 (0.42) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL7562101 | 0.86 | ALDH1A1 (0.45) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL4234474 | 0.86 | BCHE (0.65) | BCHEL3MBTL1KDM4E | |
| SCHEMBL4226049 | 0.85 | FEN1 (0.44) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL28498314 | 0.83 | BCHE (0.47) | BCHEMAPTTDP1L3MBTL1ALDH1A1 | |
| SCHEMBL7950845 | 0.83 | MAOB (0.46) | BCHEMAPTTDP1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7141684-B2 | Diepoxide derivatives of diallyl phenolics | PEWS R GARTH | 2006-11-28 | — | — | US | disclosed |
| US-20050090673-A1 | Novel diepoxide derivatives of diallyl phenolics | PEWS R G (US) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090673-A1 | Novel diepoxide derivatives of diallyl phenolics | EBP, EED, ESR2 | BCHE 3243/4885MAPT 4378/4885TDP1 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.